The effect of a smartphone-based educational intervention on the supportive care needs of family caregivers of patients with colorectal cancer: a randomized controlled trial.

Support Care CancerSep 5, 2026 (epub)
Clinical ResearchOncology (Medical)GastroenterologyOpen access

Haniyeh Nemati, Maryam Ehsani, Mansoureh Ashghali Farahani et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the impact of a smartphone-based educational program on the supportive care needs of family caregivers of colorectal cancer patients. Conducted with 80 caregivers, the study found that those receiving the intervention reported significantly greater reductions in supportive care needs compared to the control group (p < 0.001).

Key findings

  • The intervention group showed a significant reduction in total supportive care needs compared to the control group (p < 0.001).
  • Improvements were noted across all dimensions: health care service needs, psychological and emotional needs, work and social needs, and information needs.
  • The total score of the Supportive Care Needs Survey ranged from 39 to 195, indicating varying levels of supportive care needs.

Why it matters

Understanding and addressing the supportive care needs of family caregivers is crucial, as they play a vital role in the care of patients with colorectal cancer. Effective interventions can enhance their well-being and ability to provide care.

Source

PubMed · PMID 42700222Free full text on PubMed Central

Published in Support Care Cancer. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.